Jul 2026· Cancer Research· Vol 86, pp. P92-P92· 0 citations
TL;DR
The data suggests that C11ORF68 potentially acts as a repressor of inflammatory response under normal and replication stress conditions, and may also be a mediator of early DDR.
Abstract
Unresolved replication stress (RS) or DNA damage, and inflammation often lead to genomic instability – a feature of many diseases including cancer. Therefore, understanding the molecular foundation of these phenomena is crucial for identifying potential biomarkers or therapeutic targets. Our lab has identified an uncharacterized protein that is symmetrically dimethylated by PRMT5 under hydroxyurea (HU)-induced RS. Therefore, we hypothesize that C11ORF68 is involved in inflammatory and RS response.
MCF10A normal breast epithelial cells was used. Depletion of C11ORF68 using siRNA and dicer siRNA (dsiRNA) systems were used to evaluate its function. RNA-seq, qPCR, western blotting and immunofluorescence were used to evaluate the basal and HU-induced inflammatory response.
RNA-seq of C11ORF68-depleted cells displayed a basal and RS-induced upregulation of several inflammatory response pathways including interferon alpha and gamma response, and TNF signaling via NF-kB. Selected genes such as CXCL10 and IFIT1 were validated to be upregulated at both basal and RS conditions. This increase in inflammatory gene transcription may be due accumulation of dsDNA in the cytoplasm of C11ORF68-depleted cells. The mechanism of dsDNA leakage into the cytoplasm is currently being investigated. Surprisingly, the observation of cytoplasmic dsDNA was not accompanied with increased DNA damage as there was no basal increase in DNA damage or RS markers such as γH2AX and 53BP1. However, C11ORF68-depleted cells exhibited attenuated activation of DNA damage/RS pathways such as lowered PIKK activation and less repair foci formation after addition of DNA damaging/RS agents.
Our data suggests that C11ORF68 potentially acts as a repressor of both basal and RS-induced inflammatory response. C11ORF68 may also be a mediator of early DDR. Mechanisms behind how a nucleolar protein plays role in regulating these phenomena are underway, which may help us understand the involvement of a nucleolar protein in controlling inflammatory and DNA damage/RS responses.
Toh Chin Min Clarissa, Hoang Mai Phuong, Hong Liang, Anand Jeyasekharan. C11ORF68 is a repressor of inflammatory response under normal and replication stress conditions [abstract]. In: Proceedings of Frontiers in Cancer Science 2025; 2025 Nov 5-7; Singapore. Philadelphia (PA): AACR; Cancer Res 2026;86(13_Suppl):Abstract nr P92.
Genome-wide CRISPR screens have systematically identified genes required for cancer cell survival, yet these studies are typically performed under standardized conditions that do not fully recapitulate the physiological stresses encountered within the tumor microenvironment. In a recent issue of Nature Genetics, Cherui...
Zihan Ning, Guangchuan Wang· Cancer Research· 0 citations
A ubiquitous RBP, YBX1, prevents noncoding RNAs synthesized by RNA polymerase III from being recognized as DAMPs under cellular homeostasis, preventing inappropriate activation of innate immunity.
Tania Strilets, Sarah Dremel, Mariano A. García-Blanco· Proceedings of the National...· 0 citations
Findings highlight a HuR-SerpinB9 axis that regulates T-cell senescence and persistence, offering a potential therapeutic target in cancer and autoimmune diseases.
P. Chakraborty, Mrinmoyee Majumder, W. Wofford et al.· Journal of Immunology· 0 citations
A mechanism wherein SChLAP1 modulates AR signaling to promote PCa growth and progression is suggested, suggesting its molecular mechanism and potential to be used as a therapeutic target or biomarker.
Deletion of MEX3B inhibited caspase-4 and gasdermin D activation, pyroptosis, and secretion of inflammasome-dependent inflammatory cytokines in human cell lines and murine primary macrophages and suggested that MEX3B is a pan-inflammasome regulator targeting inflammatory caspases.
Peng-Hua Wang, Jason G. Cahoon, Duo-Meng Yang et al.· Journal of Immunology· 0 citations
Emerging evidence has expanded the functional repertoire of SKP2 beyond cell cycle control to encompass metabolism, DNA repair, stemness, tumor microenvironment and immunotherapy response, positioning it as an increasingly attractive target for intervention.
Sheng-An Zheng, Cheng Wang, Xiao-Die Yao et al.· Drug Design, Development and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.